Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release

Tissue Engineering - Part A

Volumn 17, Issue 13-14, 2011, Pages 1735-1746

  Brown, Kate V ^a   Li, Bing ^b,d   Guda, Teja ^a,c   Perrien, Daniel S ^b   Guelcher, Scott A ^b   Wenke, Joseph C ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d GE GLOBAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COMPUTERIZED TOMOGRAPHY; DEFECTS; FRACTURE; PHARMACOKINETICS; RATS; SCAFFOLDS (BIOLOGY);

BIODEGRADABLE POLYURETHANES; BONE FORMATION; BONE INJURY; BONE MORPHOGENETIC PROTEIN-2; BURST RELEASE; COLLAGEN SPONGE; COMPOSITE SCAFFOLDS; DEFECT MODEL; DELIVERY SYSTEMS; ECTOPIC BONES; MICROCOMPUTED TOMOGRAPHY; OPTIMAL RELEASE; OSTEOGENIC EFFECTS; RAT FEMUR; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2); RELEASE KINETICS; RHBMP-2; SUSTAINED RELEASE;

BONE;

RATTUS;

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYURETHAN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CATTLE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMUR; HUMAN; IMPLANT; KINETICS; PATHOLOGY; RADIOGRAPHY; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CATTLE; COLLAGEN; FEMUR; HUMANS; IMPLANTS, EXPERIMENTAL; KINETICS; LACTIC ACID; MICROSPHERES; OSTEOGENESIS; POLYGLYCOLIC ACID; POLYURETHANES; RATS; RECOMBINANT PROTEINS; TISSUE SCAFFOLDS; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 79959555090     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0446     Document Type: Article

References (53)

1. Harris, A. M., Althausen, P. L., Kellam, J., Bosse, M. J., and Castillo, R. Complications following limb-threatening lower extremity trauma. J Orthop Trauma 23, 1, 2009.
2. Seeherman, H., Li, R., Bouxsein, M., Kim, H., Li, X. J., Smith-Adaline, E. A., Aiolova, M., and Wozney, J. M. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg 88-A, 144, 2006.
3. Li, R. H., Bouxsein, M. L., Blake, C. A., D'Augusta, D., Kim, H., Li, X. L., Wozney, J. M., and Seeherman, H. J. rhBMP-2 injected ina calcium phospahte paste (alpha-BSM) accelerates healing in the rabbit ulnar osteotomy model. J Orthop Res 21, 997, 2001.
4. Chen, X. Q., Kidder, L. S., and Lew, W. D. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthopaedic Res 20, 142, 2002.
5. Patel, Z. S., Young, S., Tabata, Y., Jansen, J. A., Wong, M. E., and Mikos, A. G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
6. Kempen, D. H., Kruyt, M. C., Lu, L., Wilson, C. E., Florschutz, A. V., Creemers, L. B., Yaszemski, M. J., and Dhert, W. J. Effect of autologous BMSCs seeding and BMP-2 delivery on ectopic bone formation in a microsphere/poly (propylene fumarate) composite. Tissue Eng Part A 15, 587, 2009.
7. Swiontkowski, M. F., Aro, H. T., Donell, S., Esterhai, J. L., Goulet, J., Jones, A., Kregor, P. J., Nordsletten, L., Paiement, G., and Patel, A. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88, 1258, 2006.
8. Govender, S., Csimma, C., Genant, H. K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M. G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R. L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P. M., Rondia, J., Rossouw, W. C., Daneel, P. J., Ruff, S., Rüter, A., Santavirta, S., Schildhauer, T. A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R. B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., Wisniewski, T., and BESTT Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg 84-A, 2123, 2002.
9. Urist, M. R. Bone morphogenetic protein: the molecularization of the skeletal system. J Bone Min Res 12, 343, 1997.
10. Cheng, H., Jiang, W., Phillips, F. M., Haydon, R. C., Peng, Y., Zhou, L., Luu, H. H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J. P., Park, J. Y., and He, T. C. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg 85-A, 1544, 2003.
11. Fiedler, J., Roderer, G., Gunther, K. P., and Brenner, R. E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87, 305, 2002.
12. Uludag, H., Gao, T., Porter, T., Friess, W., and Wozney, J. Delivery systems for BMPS: factors contributing to the protein retention at an application site. J Bone Joint Surg 83-A, S128, 2001.
13. Seeherman, H., and Wozney, J. M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16, 329, 2005.
14. Cho, T. J., Gerstenfeld, L. C., and Einhorn, T. A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17, 513, 2002.
15. Tagil, M., Jeppsson, C., Wang, J. S., and Aspenberg, P. No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model. Acta Orthop Scand 74, 742, 2003.
16. Kloen P. Commentary & Perspective on "Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects" by Alan L. Jones, MD, et al. Available at www.ejbjs.org/Comments/2006/cp-jul06-kloen. dtl. 2006.
17. Kempen, D. H., Lu, L., Heijink, A., Hefferan, T. E., Creemers, L. B., Maran, A., Yaszemski, M. J., and Dhert, W. J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
18. Patel, Z. S., Young, S., Tabata, Y., Jansen, J. A., Wong, M. E., and Mikos, A. G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
19. Kempen, D. H., Kruyt, M. C., Lu, L., Wilson, C. E., Florschutz, A. V., Creemers, L. B., Yaszemski, M. J., and Dhert, W. J. Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly (propylene fumarate) composite. Tissue Eng Part A 15, 587, 2009.
20. Kim, S. S., Gwak, S. J., and Kim, B. S. Orthotopic bone formation by implantation of apatite-coated poly (lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A 87, 245, 2008.
21. Jeon, O., Song, S. J., Yang, H. S., Bhang, S. H., Kang, S. W., Sung, M. A, Lee, J. H. and Kim, B. S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369, 774, 2008.
22. de Jesus Perez, V. A., Alastalo, T. P., Wu, J. C., Axelrod, J. D., Cooke, J. P., Amieva, M., and Rabinovitch, M. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol 184, 83, 2009.
23. Li, R. H., and Wozney, J. M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19, 255, 2001.
24. Haidar, Z. S., Hamdy, R. C., and Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 31, 1825, 2009.
25. Haidar, Z. S., Hamdy, R. C., and Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Biotechnol Lett 31, 1817, 2009.
26. Guan, J., Stankus, J. J., and Wagner, W. R. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release 120, 70, 2007.
27. Li, B., Davidson, J. M., and Guelcher, S. A. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 30, 3486, 2009.
28. Hafeman, A., Li, B., Yoshii, T., Zienkiewicz, K., Davidson, J. M., and Guelcher, S. A. Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration. Pharm Res 25, 2387, 2008.
29. Li, B., Brown, K. V., Wenke, J. C., and Guelcher, S. A. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J Control Release 145, 221, 2010
30. Hafeman, A. E., Zienkiewicz, K. J., Carney, E., Litzner, B., Stratton, C., Wenke, J. C., and Guelcher, S. A. Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds. J Biomater Sci Polym Ed 21, 95, 2010.
31. Zhang, J. Y., Beckman, E. J, Hu, J., Yuang, G. G., Agarwal, S., and Hollinger, J. O. Synthesis, biodegradability, and biocompatibility of lysine diisocyanate-glucose polymers. Tissue Eng 8, 771, 2002.
32. Zhang J. Y., Beckman, E. J., Piesco, N. J., and Agarwal, S. A new peptide-based urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro. Biomaterials 21, 1247, 2000.
33. Gorna, K., and Gogolewski, S. Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly (epsilon-caprolactone)-poly (ethylene oxide) diols and various chain extenders. J Biomed Mater Res 60, 592, 2002.
34. Adhikari, R., Gunatillake, P. A., Griffiths, I., Tatai, L., Wickramaratna, M., Houshyar, S., Moore, T., Mayadunne, R. T., Field, J., McGee, M., and Carbone, T. Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications. Biomaterials 29, 3762, 2008.
35. Dumas, J. E., Zienkiewicz, K., Tanner, S. A., Prieto, E. M., Bhattacharyya, S., and Guelcher, S. A. Synthesis and characterization of an injectable allograft bone/polymer composite bone void filler with tunable mechanical properties. Tissue Eng Part A 16, 2505, 2010
36. Guelcher, S., Srinivasan, A., Hafeman, A., Gallagher, K., Doctor, J., Khetan, S., McBride, S., and Hollinger, J. Synthesis, In vitro degradation, and mechanical properties of twocomponent poly (ester urethane) urea scaffolds: effects of water and polyol composition. Tissue Eng 13, 2321, 2007.
37. Li, B., Yoshii, T., Hafeman, A. E., Nyman, J. S., Wenke, J. C., and Guelcher, S. A. The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials 30, 6768, 2009.
38. Talwar, R., Di Silvio, L., Hughes, F. J., and King, G. N. Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J Clin Periodontol 28, 340, 2001.
39. Arosarena, O. A., and Collins, W. L. Defect repair in the rat mandible with bone morphogenic protein 5 and prostaglandin E1. Arch Otolaryngol Head Neck Surg 129, 1125, 2003.
40. Morgan, E. F., Mason, Z. D., Chien, K. B., Pfeiffer, A. J., Barnes, G. L., Einhorn, T. A., and Gerstenfeld, L. C. Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 44, 335, 2009.
41. Suva, L. J., Seedor, J. G., Endo, N., Quartuccio, H. A., Thompson, D. D., Bab, I., and Rodan. G. A. Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 8, 379, 1993.
42. Willie, B. M., Petersen, A., Schmidt-Bleek, K., Cipitria, A., Mehta, M., Strube, P., Lienau, J., Wildemann, B., Fratzl, P., and Duda, G. Designing biomimetic scaffolds for bone regeneration: why aim for a copy of mature tissue properties if nature uses a different approach? Soft Mater 6, 4976, 2010.
43. Luginbuehl, V., Meinel, L., Merkle, H. P., and Gander, B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58, 197, 2004.
44. Morishita, Y., Naito, M., Miyazaki, M., He, W., Wu, G, Wei, F., Sintuu, C., Hymanson, H., Brochmann, E. J., Murray, S. S., and Wang, J. C. Enhanced effects of BMP-binding peptide combined with recombinant human BMP-2 on the healing of a rodent segmental femoral defect. J Orthop Res 28, 258, 2010.
45. Herford, A. S., and Boyne, P. J. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66, 616, 2008.
46. Carter, T. G., Brar, P. S., Tolas, A., and Beirne, O. R. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 66, 1417, 2008.
47. Winn, S. R., Uludag, H., and Hollinger, J. O. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31, 303, 1998.
48. Bailon-Plaza, A., and van der Meulen, M. C. A mathematical framework to study the effects of growth factor influences on fracture healing. J Theor Biol 212, 191, 2001.
49. Hafeman, A. E., Zienkiewicz, K. J., Zachman, A. L., Sung, H. J., Nanney, L. B., Davidson, J. M., and Guelcher, S. A. Characterization of the degradation mechanisms of lysinederived aliphatic poly (ester urethane) scaffolds. Biomaterials 32, 419, 2011.
50. Jeon, O., Song, S. J., Kang, S. W., Putnam, A. J., and Kim, B. S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly (L-lactic-co-glycolic acid) scaffold. Biomaterials 28, 2763, 2007.
51. Kempen, D. H., Lu, L., Heijink, A., Hefferan, T. E., Creemers, L. B., Maran, A., Yaszemski, M. J., and Dhert, W. J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
52. Kempen, D. H., Lu, L., Hefferan, T. E., Creemers, L. B., Maran, A., Classic, K. L., Dhert, W. J., and Yaszemski, M. J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29, 3245, 2008.
53. Khan, Y., Yaszemski, M. J., Mikos, A. G., and Laurencin, C. T. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg 90 A, S36, 2008.